Style | Citing Format |
---|---|
MLA | Bashiri Z, et al.. "Retraction Notice to “In-Vitro and In-Vivo Evaluation of Angiogenic Potential of a Novel Lithium Chloride Loaded Silk Fibroin/Alginate 3D Porous Scaffold With Antibacterial Activity, for Promoting Diabetic Wound Healing” [Int. J. Biol. Macromol. 277(2024) 134362] (International Journal of Biological Macromolecules (2024) 277(P4), (S0141813024051675), (10.1016/J.Ijbiomac.2024.134362))." International Journal of Biological Macromolecules, vol. 307, no. , 2025, pp. -. |
APA | Bashiri Z, Sharifi AM, Ghafari M, Hosseini SJ, Shahmahmoodi Z, Moeinzadeh A, Parsaei H, Khadivi F, Afzali A, Koruji M (2025). Retraction Notice to “In-Vitro and In-Vivo Evaluation of Angiogenic Potential of a Novel Lithium Chloride Loaded Silk Fibroin/Alginate 3D Porous Scaffold With Antibacterial Activity, for Promoting Diabetic Wound Healing” [Int. J. Biol. Macromol. 277(2024) 134362] (International Journal of Biological Macromolecules (2024) 277(P4), (S0141813024051675), (10.1016/J.Ijbiomac.2024.134362)). International Journal of Biological Macromolecules, 307(), -. |
Chicago | Bashiri Z, Sharifi AM, Ghafari M, Hosseini SJ, Shahmahmoodi Z, Moeinzadeh A, Parsaei H, Khadivi F, Afzali A, Koruji M. "Retraction Notice to “In-Vitro and In-Vivo Evaluation of Angiogenic Potential of a Novel Lithium Chloride Loaded Silk Fibroin/Alginate 3D Porous Scaffold With Antibacterial Activity, for Promoting Diabetic Wound Healing” [Int. J. Biol. Macromol. 277(2024) 134362] (International Journal of Biological Macromolecules (2024) 277(P4), (S0141813024051675), (10.1016/J.Ijbiomac.2024.134362))." International Journal of Biological Macromolecules 307, no. (2025): -. |
Harvard | Bashiri Z et al. (2025) 'Retraction Notice to “In-Vitro and In-Vivo Evaluation of Angiogenic Potential of a Novel Lithium Chloride Loaded Silk Fibroin/Alginate 3D Porous Scaffold With Antibacterial Activity, for Promoting Diabetic Wound Healing” [Int. J. Biol. Macromol. 277(2024) 134362] (International Journal of Biological Macromolecules (2024) 277(P4), (S0141813024051675), (10.1016/J.Ijbiomac.2024.134362))', International Journal of Biological Macromolecules, 307(), pp. -. |
Vancouver | Bashiri Z, Sharifi AM, Ghafari M, Hosseini SJ, Shahmahmoodi Z, Moeinzadeh A, et al.. Retraction Notice to “In-Vitro and In-Vivo Evaluation of Angiogenic Potential of a Novel Lithium Chloride Loaded Silk Fibroin/Alginate 3D Porous Scaffold With Antibacterial Activity, for Promoting Diabetic Wound Healing” [Int. J. Biol. Macromol. 277(2024) 134362] (International Journal of Biological Macromolecules (2024) 277(P4), (S0141813024051675), (10.1016/J.Ijbiomac.2024.134362)). International Journal of Biological Macromolecules. 2025;307():-. |
BibTex | @article{ author = {Bashiri Z and Sharifi AM and Ghafari M and Hosseini SJ and Shahmahmoodi Z and Moeinzadeh A and Parsaei H and Khadivi F and Afzali A and Koruji M}, title = {Retraction Notice to “In-Vitro and In-Vivo Evaluation of Angiogenic Potential of a Novel Lithium Chloride Loaded Silk Fibroin/Alginate 3D Porous Scaffold With Antibacterial Activity, for Promoting Diabetic Wound Healing” [Int. J. Biol. Macromol. 277(2024) 134362] (International Journal of Biological Macromolecules (2024) 277(P4), (S0141813024051675), (10.1016/J.Ijbiomac.2024.134362))}, journal = {International Journal of Biological Macromolecules}, volume = {307}, number = {}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Bashiri Z AU - Sharifi AM AU - Ghafari M AU - Hosseini SJ AU - Shahmahmoodi Z AU - Moeinzadeh A AU - Parsaei H AU - Khadivi F AU - Afzali A AU - Koruji M TI - Retraction Notice to “In-Vitro and In-Vivo Evaluation of Angiogenic Potential of a Novel Lithium Chloride Loaded Silk Fibroin/Alginate 3D Porous Scaffold With Antibacterial Activity, for Promoting Diabetic Wound Healing” [Int. J. Biol. Macromol. 277(2024) 134362] (International Journal of Biological Macromolecules (2024) 277(P4), (S0141813024051675), (10.1016/J.Ijbiomac.2024.134362)) JO - International Journal of Biological Macromolecules VL - 307 IS - SP - EP - PY - 2025 ER - |